China Pharma Holdings (CPHI)

$0.71 -0.01 (-0.82%)
Market Cap 29.01M
Revenue (ttm) 4.14M
Net Income (ttm) -3.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -77.05%
Debt to Equity Ratio 0.05
Volume 27,150
Avg Vol 342,896
Day's Range N/A - N/A
Shares Out 40.52M
Stochastic %K 3%
Beta 1.16
Analysts Strong Buy
Price Target $4.50

Company Profile

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylg...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 86 89 8668 11730
Fax: 86 89 8668 19024
Address:
No. 17, Jinpan Road, Second Floor, Haikou, China
Rampart1
Rampart1 Jun. 3 at 7:05 PM
$CPHI lvl 2 looks wild.
0 · Reply
JMJTrading
JMJTrading May. 29 at 2:16 PM
$MX Buy alert here, bigger dip than I expected off the highs, but my average is $7.92 and holding for the teens. Lets see that bounce here. Added for the last time, complete position now at just over 10,000 shares. $JBDI $KIDZ $CPHI
1 · Reply
PurpleEagle
PurpleEagle May. 26 at 2:57 PM
$CPHI Citadel Advisors purchased 13,000 shares of CPHI on March 31, 2026. Citadel Advisors LLC is a premier global alternative investment firm that serves as the primary investment manager for the Citadel hedge funds, overseeing approximately 68 billion in investment capital
0 · Reply
Rampart1
Rampart1 May. 26 at 2:14 PM
$CPHI slowly moved up .
0 · Reply
Rampart1
Rampart1 May. 22 at 9:03 PM
$CPHI looks good here.
0 · Reply
PurpleEagle
PurpleEagle May. 21 at 2:44 PM
$CPHI https://www.panabee.com/news/china-pharma-acquires-sublingual-tablet-patent-in-6-9-million-stock-deal
0 · Reply
PurpleEagle
PurpleEagle May. 21 at 2:42 PM
$CPHI https://www.sec.gov/Archives/edgar/data/1106644/000121390026014338/ea027636901ex10-1_china.htm
0 · Reply
LargeSodaDrinker
LargeSodaDrinker May. 21 at 6:03 AM
$CREG $BABA $BNSOF $CPHI $CREG Are you comparing CREG to BABA? You are insane
3 · Reply
lsoto
lsoto May. 21 at 4:33 AM
$CREG Remember when $BABA was at $66, just two years ago? Today its more than double. I have bought and sold Chinese stocks several times with good success, like $BNSOF, $CPHI and now $CREG The intrinsic value is there. All we need is time and patience, sooner or later, we will do well!
0 · Reply
Rampart1
Rampart1 May. 20 at 5:17 PM
$CPHI on watch for Ebola run on this one also.
0 · Reply
Latest News on CPHI
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

May 14, 2026, 8:56 AM EDT - 25 days ago

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

China Pharma announces 1-for-10 reverse stock split

2025-04-04T20:10:41.000Z - 1 year ago

China Pharma announces 1-for-10 reverse stock split

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

Apr 4, 2025, 4:05 PM EDT - 1 year ago

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

Dec 18, 2024, 8:30 AM EST - 1 year ago

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

China Pharma announces $600,000 common stock offering

2024-12-13T13:05:34.000Z - 1 year ago

China Pharma announces $600,000 common stock offering

China Pharma Announces the Entry of "At-The-Market" Equity Offering

Dec 13, 2024, 8:00 AM EST - 1 year ago

China Pharma Announces the Entry of "At-The-Market" Equity Offering

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

Aug 19, 2024, 8:00 AM EDT - 1 year ago

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

Feb 23, 2024, 4:05 PM EST - 2 years ago

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

Nov 29, 2023, 8:00 AM EST - 2 years ago

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

Aug 9, 2023, 8:30 AM EDT - 3 years ago

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

Dec 28, 2022, 8:00 AM EST - 3 years ago

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

Dec 15, 2022, 8:00 AM EST - 3 years ago

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

Dec 5, 2022, 8:00 AM EST - 3 years ago

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

Dec 2, 2022, 4:10 PM EST - 3 years ago

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

Oct 1, 2022, 10:05 PM EDT - 4 years ago

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

Jul 18, 2022, 8:00 AM EDT - 4 years ago

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

Mar 31, 2022, 8:00 AM EDT - 4 years ago

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

Nov 12, 2021, 4:30 PM EST - 4 years ago

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

Aug 13, 2021, 4:30 PM EDT - 5 years ago

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

Aug 5, 2021, 9:00 AM EDT - 5 years ago

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

China Pharma to Launch Highly Purified NMN+PQQ Product

Jun 9, 2021, 8:00 AM EDT - 5 years ago

China Pharma to Launch Highly Purified NMN+PQQ Product

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

May 14, 2021, 4:30 PM EDT - 5 years ago

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

Apr 19, 2021, 8:30 AM EDT - 5 years ago

China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

Mar 26, 2021, 5:00 PM EDT - 5 years ago

China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

Rampart1
Rampart1 Jun. 3 at 7:05 PM
$CPHI lvl 2 looks wild.
0 · Reply
JMJTrading
JMJTrading May. 29 at 2:16 PM
$MX Buy alert here, bigger dip than I expected off the highs, but my average is $7.92 and holding for the teens. Lets see that bounce here. Added for the last time, complete position now at just over 10,000 shares. $JBDI $KIDZ $CPHI
1 · Reply
PurpleEagle
PurpleEagle May. 26 at 2:57 PM
$CPHI Citadel Advisors purchased 13,000 shares of CPHI on March 31, 2026. Citadel Advisors LLC is a premier global alternative investment firm that serves as the primary investment manager for the Citadel hedge funds, overseeing approximately 68 billion in investment capital
0 · Reply
Rampart1
Rampart1 May. 26 at 2:14 PM
$CPHI slowly moved up .
0 · Reply
Rampart1
Rampart1 May. 22 at 9:03 PM
$CPHI looks good here.
0 · Reply
PurpleEagle
PurpleEagle May. 21 at 2:44 PM
$CPHI https://www.panabee.com/news/china-pharma-acquires-sublingual-tablet-patent-in-6-9-million-stock-deal
0 · Reply
PurpleEagle
PurpleEagle May. 21 at 2:42 PM
$CPHI https://www.sec.gov/Archives/edgar/data/1106644/000121390026014338/ea027636901ex10-1_china.htm
0 · Reply
LargeSodaDrinker
LargeSodaDrinker May. 21 at 6:03 AM
$CREG $BABA $BNSOF $CPHI $CREG Are you comparing CREG to BABA? You are insane
3 · Reply
lsoto
lsoto May. 21 at 4:33 AM
$CREG Remember when $BABA was at $66, just two years ago? Today its more than double. I have bought and sold Chinese stocks several times with good success, like $BNSOF, $CPHI and now $CREG The intrinsic value is there. All we need is time and patience, sooner or later, we will do well!
0 · Reply
Rampart1
Rampart1 May. 20 at 5:17 PM
$CPHI on watch for Ebola run on this one also.
0 · Reply
Rampart1
Rampart1 May. 19 at 7:50 PM
$CPHI bounced at support.
0 · Reply
ndowns
ndowns May. 18 at 10:21 PM
$CPHI is just another China piece of shit. Extremely manipulated and no value. Dump it.
1 · Reply
PurpleEagle
PurpleEagle May. 17 at 12:35 PM
$CPHI Many new products to sell - more dilution for stockholders. So, start selling some of those products and become profitable.
0 · Reply
PurpleEagle
PurpleEagle May. 17 at 12:28 PM
$CPHI Hainan Helpson Medical & Biotechnology, a subsidiary of China Pharma, signed a technology transfer agreement with Xiaoyan Zhang on February 26, 2026. The agreement secures ownership of an invention patent for Prinsepia Utilis Esterol Sublingual Tablets and the associated manufacturing methods. China Pharma is a specialty pharmaceutical company focused on developing and manufacturing healthcare products for the Chinese market. The acquisition is priced at $6.9 million, which the company will settle by issuing 12.6 million restricted common shares at $0.55 per share. The shares are being issued under Regulation S, indicating an offshore transaction with a non-U.S. person. This all-stock structure allows the company to expand its intellectual property portfolio without immediate cash outlays, though it results in dilution for existing shareholders.
0 · Reply
PurpleEagle
PurpleEagle May. 17 at 12:26 PM
$CPHI China Pharma Holdings reached a definitive agreement to acquire an invention patent for a Topiroxostat nanoemulsion and its preparation method. The company's subsidiary, Helpson Medical & Biotechnology, signed the deal with Xiaoyun Chen on February 5, 2026. This acquisition targets the gout and hyperuricemia market, as Topiroxostat is a xanthine oxidase inhibitor used to manage uric acid levels. The transaction is valued at $8.8 million. China Pharma Holdings will settle the total amount through the issuance of 12.6 million restricted shares of common stock. These shares are priced at $0.70 per share, reflecting a structured approach to preserving cash while expanding the company's intellectual property portfolio. The closing of this technology transfer is expected by February 20, 2026.
0 · Reply
PurpleEagle
PurpleEagle May. 16 at 1:45 AM
$CPHI 10Q is out! 3/31/26 Revenue of $983,536 compared to 3/31/26 $1,136,287. Net loss of $1,143,148 compared to NL of $785,572 in Q1 '25. Working capital was <5,264,123> with $2,003,555 in current assets and $7,267,678 in current liabilities. Equity increased from $22,739,572 at Q1 2025 to $37,024,190 in Q1 2026 as more intangibles were recorded in February 2026. The Xiaoyum Chen agreement for "Topiroxostat Nano Emulsion" and the Xiaoyan Zhang agreement for Prinsepia Utilis Esterol Tablets. The accumulated deficit was $48,357,383. Must have ass-kicker of tax loss carry forward/back!
0 · Reply
Bank_of_Gotham
Bank_of_Gotham May. 15 at 1:59 PM
$CPHI Stay strong stay long bulls
0 · Reply
Investor_Scale
Investor_Scale May. 14 at 9:28 PM
$CPHI
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 14 at 8:52 PM
$CPHI closed at it... classic
0 · Reply
topstockalerts
topstockalerts May. 14 at 8:35 PM
$CPHI I’m beginning to think this isn’t a one-candle wonder.
0 · Reply
realditzy
realditzy May. 14 at 7:54 PM
$CPHI where do we think this can go ?
2 · Reply
Rampart1
Rampart1 May. 14 at 6:20 PM
$CPHI shorts are trying. but they the ones getting burned. so i doubt it will fall much. we shll see.
0 · Reply